Page last updated: 2024-09-04

disufenton sodium and Hemorrhage

disufenton sodium has been researched along with Hemorrhage in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashwood, T; Davalos, A; Davis, SM; Diener, HC; Grotta, J; Hårdemark, HG; Lees, KR; Lyden, P; Shuaib, A; Wasiewski, WW; Zivin, JA	1
Dávalos, A; Ferro, JM	1
Serebruany, V	1
Fisher, M	1
Hess, DC	1

Trials

1 trial(s) available for disufenton sodium and Hemorrhage

Article	Year
NXY-059 for acute ischemic stroke. The New England journal of medicine, 2006, Feb-09, Volume: 354, Issue:6 Topics: Acute Disease; Benzenesulfonates; Brain Ischemia; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Nervous System Diseases; Neuroprotective Agents; Nitrogen Oxides; Severity of Illness Index; Stroke; Time Factors; Tissue Plasminogen Activator; Treatment Outcome	2006

Article

Year

NXY-059 for acute ischemic stroke.

The New England journal of medicine, 2006, Feb-09, Volume: 354, Issue:6

Topics: Acute Disease; Benzenesulfonates; Brain Ischemia; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Nervous System Diseases; Neuroprotective Agents; Nitrogen Oxides; Severity of Illness Index; Stroke; Time Factors; Tissue Plasminogen Activator; Treatment Outcome

2006

Other Studies

4 other study(ies) available for disufenton sodium and Hemorrhage

Article	Year
Other neuroprotective therapies on trial in acute stroke. Cerebrovascular diseases (Basel, Switzerland), 2006, Volume: 21 Suppl 2 Topics: Anti-Inflammatory Agents; Benzenesulfonates; Drug Combinations; Free Radical Scavengers; Glucose; Hemorrhage; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Interferon beta-1a; Interferon-beta; Neuroprotective Agents; Potassium; Randomized Controlled Trials as Topic; Recombinant Proteins; Stroke; Tissue Plasminogen Activator	2006
NXY-059 for acute ischemic stroke. The New England journal of medicine, 2006, May-11, Volume: 354, Issue:19 Topics: Acute Disease; Benzenesulfonates; Brain Ischemia; Cardiovascular Agents; Data Interpretation, Statistical; Hemorrhage; Humans; Nitrogen Oxides; Stroke	2006
NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized? Stroke, 2006, Volume: 37, Issue:10 Topics: Benzenesulfonates; Biomarkers; Clinical Trials, Phase III as Topic; Double-Blind Method; Fibrinolytic Agents; Free Radical Scavengers; Hemorrhage; Humans; Neuroprotective Agents; Nitrogen Oxides; Randomized Controlled Trials as Topic; Sample Size; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2006
NXY-059: a hopeful sign in the treatment of stroke. Stroke, 2006, Volume: 37, Issue:10 Topics: Animals; Benzenesulfonates; Callithrix; Chlormethiazole; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Fibrinolytic Agents; Free Radical Scavengers; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitrogen Oxides; Pyridines; Randomized Controlled Trials as Topic; Research Design; Rodentia; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2006